Study Stopped
Challenges with recruitment
Mask Adhesive Institutional Study
Feasibility Study of a Mask Adhesive in Patients Treated With NIV in an Institutional Setting
1 other identifier
interventional
7
1 country
1
Brief Summary
To reduce interface leak and aerosol spread, Philips has developed an accessory to non-invasive ventilation(NIV) masks to be used with the Philips AF531 and the PerformaTrak mask on respiratory failure patients. For the purposes of capturing initial mask leak and safety data, this trial will enroll patients treated with NIV in an institutional setting (i.e., sleep lab).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 18, 2020
CompletedFirst Posted
Study publicly available on registry
November 25, 2020
CompletedStudy Start
First participant enrolled
February 17, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 9, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 9, 2021
CompletedResults Posted
Study results publicly available
May 26, 2023
CompletedMay 26, 2023
May 1, 2023
10 months
November 18, 2020
December 8, 2022
May 24, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
Medical Adhesive-Related Skin Injury (MARSI)
Percentage of patients who have severe and extreme skin irritation that persists for ≥ 30 min after mask adhesive removal (score of ≥ 3 on a 5-point grading system).
Up to 5 business days
Clinician Ease of Use
Clinician-perceived mask adhesive ease-of-use as measured by a 0-10 Likert Scale at baseline (initial impressions) and study completion (overall impressions) Specifically, the item, "How would you rate the ease of application of the adhesive to the mask?" (On a 0 to 10 scale, with 0=Extremely Difficult and 10=Extremely Easy)
Initial Impressions at Baseline and Overall Impressions at Study Completion (After at least two mask applications)
Secondary Outcomes (1)
Leak Change
Up to 5 business days
Study Arms (2)
Mask with Mask Adhesive/Arm 1
ACTIVE COMPARATORPatients will be randomized to AF531 if they receive mask adhesive with mask on the first study night then the mask without mask adhesive(Performatrak) on the second study night.
Mask without Mask Adhesive/Arm 2
PLACEBO COMPARATORPatients will be randomized to Arm 2 if they receive the mask without mask adhesive on the first study night then they will receive the mask with the mask adhesive on the second study night.
Interventions
Patients will be randomized to Arm1 if they receive the mask adhesive and mask on the first study night then the mask without the mask adhesive on the second study night.
Patients will be randomized to Arm 2 if they receive the mask without mask adhesive on the first study night then the mask adhesive with the mask on the second study night.
Eligibility Criteria
You may qualify if:
- Adults patients age 18 to 85 (inclusive)
- Adult patients treated with NIV
- Able to read, write, and speak English
- Able to provide written informed consent
- Willing to have facial hair removed for adhesive placement (if required)
You may not qualify if:
- Pre-existing allergy to tape or adhesive;
- Blisters, open skin or pre-existing skin condition that may impact the ability to support removal of the mask adhesive without tearing the skin
- pregnant (for females of childbearing age);
- Individuals sentenced to such an institution under a criminal or civil statute,
- Individuals detained in other facilities by virtue of statutes or commitment procedures which provide alternatives to criminal prosecution or incarceration in a penal institution, and individuals detained pending arraignment, trial, or sentencing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sleep Disorder Center of Alabama
Birmingham, Alabama, 35213, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Chuck Cain
- Organization
- Philips
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 18, 2020
First Posted
November 25, 2020
Study Start
February 17, 2021
Primary Completion
December 9, 2021
Study Completion
December 9, 2021
Last Updated
May 26, 2023
Results First Posted
May 26, 2023
Record last verified: 2023-05